At the core of tumor, when cancer cells are undergoing EMT, epithelial cells gain a mesenchymal phenotype (e.g., loss of E-cadherin, cytokeratin, and claudin while acquiring N-cadherin and vimentin). This evidence concerns the gene VIM and neoplasm.